| Literature DB >> 30032644 |
Nathan Katz1, Tamara Goode1, Christian Hinderer1, Juliette Hordeaux1, James M Wilson1.
Abstract
Intrathecal delivery of adeno-associated virus vectors and other therapeutics are currently being evaluated for the treatment of central nervous system sequelae of lysosomal storage diseases, motor neuron diseases, and neurodegenerative diseases. As products transition from preclinical to clinical studies, a standardized and clinically relevant method of intrathecal delivery is increasingly germane. Here, we describe a method of intrathecal delivery via suboccipital puncture into the cisterna magna under fluoroscopic guidance in nonhuman primates. This procedure is suitable for use in good laboratory practice compliant studies, has an excellent safety profile, and is highly similar to the procedure currently being explored for use in humans.Entities:
Keywords: AAV; central nervous system; gene therapy; intrathecal
Mesh:
Year: 2018 PMID: 30032644 DOI: 10.1089/hgtb.2018.041
Source DB: PubMed Journal: Hum Gene Ther Methods ISSN: 1946-6536 Impact factor: 2.396